Moderna hat einen vielversprechenden neuen Grippe-mRNA-Impfstoff. Trumps FDA will damit nichts zu tun haben | Der hochrangige FDA-Beamte Vinay Prasad hat Berichten zufolge seine Mitarbeiter überstimmt, als er beschlossen hat, den Antrag von Moderna auf eine neue saisonale Grippeimpfung abzulehnen.
https://gizmodo.com/moderna-has-a-promising-new-flu-mrna-vaccine-trumps-fda-wants-nothing-to-do-with-it-2000720609
5 Kommentare
>The federal government’s crusade against vaccines seems to have been taken up a notch. In a highly unusual move, the Food and Drug Administration has outright refused to review Moderna’s promising experimental mRNA flu vaccine for potential approval.
>Moderna revealed the FDA’s refusal Tuesday evening, posting its rejection letter online. In the letter, signed by senior official Vinay Prasad, the FDA claims that Moderna’s Phase III trial data did not include an adequate control group for comparison. Moderna has stated that it followed all the recommendations previously agreed upon with the agency. Prasad reportedly decided to reject Moderna’s application unilaterally, over the objection of FDA scientists.
>The FDA’s decision, “which did not identify any safety or efficacy concerns with our product, does not further our shared goal of enhancing America’s leadership in developing innovative medicines,” said Stéphane Bancel, Moderna CEO, in a statement from the company.
You can just expect scientific advances, particularly in the health care category, to be dead on arrival in America for the remainder of the Trump term.
And it will likely take some time to get things back on track after RFK and Oz and the other idiots are out.
And yet when it gets rolled out in other countries and proven effective, trump and rfk will claim it was made on their watch and they should get to have the patent.
More on this subject from other reputable sources:
—
– Washington Post (B): [FDA won’t review Moderna application for first mRNA-based flu vaccine](https://www.washingtonpost.com/health/2026/02/10/fda-rejects-moderna-mrna-flu-vaccine/)
– New York Times (B+): [F.D.A. Refuses to Review Moderna Flu Vaccine](https://www.nytimes.com/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html)
– Reuters (A): [FDA refuses to review Moderna’s influenza vaccine application](https://www.reuters.com/legal/litigation/moderna-says-us-fda-refuses-review-its-influenza-vaccine-2026-02-10/)
– pennlive (B+): [Kennedy-era FDA changes vaccine review process, blocks Moderna application](https://www.pennlive.com/health/2026/02/kennedy-era-fda-changes-vaccine-review-process-blocks-moderna-application.html)
—
[__Extended Summary__](https://www.reddit.com/r/newswall/comments/1r2sivc/) | [FAQ & Grades](https://www.reddit.com/r/newswall/comments/uxgfm5/faq_newswall_bot/) | I’m a bot
It will affect development in other countries who rely on the US for research. The size of the market matters for companies trying to recoup their investment. They will be less likely to proceed.